Premium
Opinion : When is Vitamin D Contraindicated in Dialysis Patients?
Author(s) -
Khosla Neenoo,
Sprague Stuart M.
Publication year - 2009
Publication title -
seminars in dialysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 78
eISSN - 1525-139X
pISSN - 0894-0959
DOI - 10.1111/j.1525-139x.2009.00567.x
Subject(s) - medicine , intensive care medicine , dialysis , vitamin d and neurology , expert opinion
Moe SM: Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45:1026–1033, 2005 5. Perwad F, Azam N, Zhang MY, Yamashita T, Tenenhouse HS, Portale AA: Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitaminDmetabolism inmice.Endocrinology 146:5358–5364, 2005 6. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T: FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone MinerRes 19:429–435, 2004 7. Dusso AS, BrownAJ, Slatopolsky E: VitaminD.AmJPhysiol 289:F8–F28, 2005 8. Usatii M, Rousseau L, Demers C, Petit JL, Brossard JH, Gascon-Barre M, Lavigne JR, Zahradnik RJ,Nemeth EF, D’Amour P: Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1,25(OH)2D synthesis.Kidney Int 72:1330–1335, 2007 9. Kremer R, Bolivar I, Goltzman D, Hendy GN: Influence of calcium and 1,25-dihydroxycholecalciferol on proliferation and proto-oncogene expression in primary cultures of bovine parathyroid cells. Endocrinology 125:935– 941, 1989 10. Naveh-ManyT,Marx R,Keshet E, Pike JW, Silver J: Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo. J Clin Invest 86:1968–1975, 1990 11. Ramirez JA, Emmett M, White MG, Fathi N, Santa Ana CA, Morawski SG, Fordtran JS: The absorption of dietary phosphorus and calcium in hemodialysis patients.Kidney Int 30:753–759, 1986 12. Brown AJ, Dusso A, Slatopolsky E: Selective vitamin D analogs and their therapeutic applications.SeminNephrol 14:156–174, 1994 13. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease inmaintenance hemodialysis patients.Kidney Int 70:771–780, 2006 14. TengM,WolfM,OfsthunMN, Lazarus JM,HernanMA, CamargoCA Jr, Thadhani R: Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J AmSocNephrol 16:1115–1125, 2005 15. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, KurokawaK, Bommer J, Piera L, Port FK: Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.Kidney Int 67:1179–1187, 2005